Trials / Completed
CompletedNCT00683410
Post-Marketing Study of the Safety of Prevenar (Pneumococcal Conjugate Vaccine, 7-valent)
A Prospective, Observational Study to Monitor Safety in Patients Who Were Administered With Pneumococcal Conjugate Vaccine, 7-valent (Prevenar) 0.5 mL by Intramuscular Injection
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 3,366 (actual)
- Sponsor
- Wyeth is now a wholly owned subsidiary of Pfizer · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Accepted
Summary
To collect post-marketing information on the safety of Prevenar in Filipino patients
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Pneumococcal Conjugate Vaccine, 7-valent (Prevenar) |
Timeline
- Start date
- 2007-04-01
- Primary completion
- 2009-10-01
- Completion
- 2009-10-01
- First posted
- 2008-05-23
- Last updated
- 2010-11-16
- Results posted
- 2010-11-16
Locations
1 site across 1 country: Philippines
Source: ClinicalTrials.gov record NCT00683410. Inclusion in this directory is not an endorsement.